{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:18:15Z","timestamp":1791011895547,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00467-010-1462-9","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T06:25:22Z","timestamp":1265869522000},"page":"609-616","source":"Crossref","is-referenced-by-count":7,"title":["New therapies: calcimimetics, phosphate binders and vitamin\u00a0D receptor activators"],"prefix":"10.1007","volume":"25","author":[{"given":"Jorge B.","family":"Cannata-And\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Rodriguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rom\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Tu\u00f1\u00f3n-le Poultel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rodr\u00edguez-Puyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,12]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","volume":"17","author":"F Locatelli","year":"2002","unstructured":"Locatelli F, Cannata-Andia JB, Drueke TB, Horl WH, Fouque D, Heimburger O, Ritz E (2002) Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 17:723\u2013731","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR2","first-page":"i2","volume":"1","author":"JB Cannata-Andia","year":"2008","unstructured":"Cannata-Andia JB, Carrera F (2008) The pathophysiology of secondary hyperparathyroidism and the consequences of uncontrolled mineral metabolism in chronic kidney disease: the role of COSMOS. Nephrol Dial Transplant Plus 1:i2\u2013i6","journal-title":"Nephrol Dial Transplant Plus"},{"key":"1462_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin\u00a0D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"1462_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","volume":"29","author":"I Martinez","year":"1997","unstructured":"Martinez I, Saracho R, Montenegro J, Llach F (1997) The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496\u2013502","journal-title":"Am J Kidney Dis"},{"key":"1462_CR5","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519\u2013530","journal-title":"Am J Kidney Dis"},{"key":"1462_CR7","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/ndt\/gfn338","volume":"23","author":"N Carrillo-Lopez","year":"2008","unstructured":"Carrillo-Lopez N, Alvarez-Hernandez D, Gonzalez-Suarez I, Roman-Garcia P, Valdivielso JM, Fernandez-Martin JL, Cannata-Andia JB (2008) Simultaneous changes in the calcium-sensing receptor and the vitamin\u00a0D receptor under the influence of calcium and calcitriol. Nephrol Dial Transplant 23:3479\u20133484","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR8","first-page":"103","volume":"29","author":"N Carrillo-Lopez","year":"2009","unstructured":"Carrillo-Lopez N, Fernandez-Martin JL, Cannata-Andia JB (2009) The role of calcium, calcitriol and its receptors in parathyroid regulation. Nefrologia 29:103\u2013108","journal-title":"Nefrologia"},{"key":"1462_CR9","first-page":"80","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"H Juppner","year":"1999","unstructured":"Juppner H, Brown EM, Kronenberg HM (1999) Parathyroid hormone. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 80\u201387","edition":"4"},{"key":"1462_CR10","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","volume":"283","author":"J Silver","year":"2002","unstructured":"Silver J, Kilav R, Naveh-Many T (2002) Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 283:F367\u2013F376","journal-title":"Am J Physiol Renal Physiol"},{"key":"1462_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","volume":"366","author":"EM Brown","year":"1993","unstructured":"Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC (1993) Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366:575\u2013580","journal-title":"Nature"},{"key":"1462_CR12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1995.2048","volume":"212","author":"AJ Brown","year":"1995","unstructured":"Brown AJ, Zhong M, Ritter C, Brown EM, Slatopolsky E (1995) Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression. Biochem Biophys Res Commun 212:861\u2013867","journal-title":"Biochem Biophys Res Commun"},{"key":"1462_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1026570518919","volume":"1","author":"EM Brown","year":"2000","unstructured":"Brown EM (2000) Calcium receptor and regulation of parathyroid hormone secretion. Rev Endocr Metab Disord 1:307\u2013315","journal-title":"Rev Endocr Metab Disord"},{"key":"1462_CR14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","volume":"86","author":"T Naveh-Many","year":"1990","unstructured":"Naveh-Many T, Marx R, Keshet E, Pike JW, Silver J (1990) Regulation of 1,25-dihydroxyvitamin\u00a0D3 receptor gene expression by 1,25-dihydroxyvitamin\u00a0D3 in the parathyroid in vivo. J Clin Invest 86:1968\u20131975","journal-title":"J Clin Invest"},{"key":"1462_CR15","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","volume":"96","author":"T Naveh-Many","year":"1995","unstructured":"Naveh-Many T, Rahamimov R, Livni N, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin\u00a0D. J Clin Invest 96:1786\u20131793","journal-title":"J Clin Invest"},{"key":"1462_CR16","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","volume":"15","author":"M Mizobuchi","year":"2004","unstructured":"Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T (2004) Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15:2579\u20132587","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR17","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","volume":"292","author":"ME Rodriguez","year":"2007","unstructured":"Rodriguez ME, Almaden Y, Canadillas S, Canalejo A, Siendones E, Lopez I, Aguilera-Tejero E, Martin D, Rodriguez M (2007) The calcimimetic R-568 increases vitamin\u00a0D receptor expression in rat parathyroid glands. Am J Physiol Renal Physiol 292:F1390\u2013F1395","journal-title":"Am J Physiol Renal Physiol"},{"key":"1462_CR18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","volume":"24","author":"M Meola","year":"2009","unstructured":"Meola M, Petrucci I, Barsotti G (2009) Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 24:982\u2013989","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S8756-3282(00)00350-1","volume":"27","author":"MA Miller","year":"2000","unstructured":"Miller MA, Fox J (2000) Daily transient decreases in plasma parathyroid hormone levels induced by the calcimimetic NPS R-568 slows the rate of bone loss but does not increase bone mass in ovariectomized rats. Bone 27:511\u2013519","journal-title":"Bone"},{"key":"1462_CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","volume":"26","author":"H Ishii","year":"2000","unstructured":"Ishii H, Wada M, Furuya Y, Nagano N, Nemeth EF, Fox J (2000) Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 26:175\u2013182","journal-title":"Bone"},{"key":"1462_CR21","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","volume":"350","author":"GA Block","year":"2004","unstructured":"Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516\u20131525","journal-title":"N Engl J Med"},{"key":"1462_CR22","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","volume":"23","author":"GA Block","year":"2008","unstructured":"Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA (2008) Combined therapy with cinacalcet and low doses of vitamin\u00a0D sterols in patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant 23:2311\u20132318","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR23","unstructured":"Bencova V, Malberti F, Ashman N (2009) \u201cReal-world\u201d use of cinacalcet in the management of SHPT among European countries. World Congress of Nephrology, Milan, May 2009. Abstract SU577"},{"key":"1462_CR24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","volume":"2","author":"GM Chertow","year":"2007","unstructured":"Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P (2007) Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol 2:898\u2013905","journal-title":"Clin J Am Soc Nephrol"},{"key":"1462_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","volume":"53","author":"M Chonchol","year":"2009","unstructured":"Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA (2009) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 53:197\u2013207","journal-title":"Am J Kidney Dis"},{"key":"1462_CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneph.2009.54","volume":"5","author":"JB Cannata-Andia","year":"2009","unstructured":"Cannata-Andia JB, Fernandez-Martin JL (2009) Mineral metabolism: should cinacalcet be used in patients who are not on dialysis? Nat Rev Nephrol 5:307\u2013308","journal-title":"Nat Rev Nephrol"},{"key":"1462_CR27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00467-007-0742-5","volume":"23","author":"DM Silverstein","year":"2008","unstructured":"Silverstein DM, Kher KK, Moudgil A, Khurana M, Wilcox J, Moylan K (2008) Cinacalcet is efficacious in pediatric dialysis patients. Pediatr Nephrol 23:1817\u20131822","journal-title":"Pediatr Nephrol"},{"key":"1462_CR28","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00467-008-0810-5","volume":"23","author":"J Muscheites","year":"2008","unstructured":"Muscheites J, Wigger M, Drueckler E, Fischer DC, Kundt G, Haffner D (2008) Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 23:1823\u20131829","journal-title":"Pediatr Nephrol"},{"key":"1462_CR29","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/ndt\/gfn143","volume":"23","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Perez EC, Oh J, Santos F, Geldyyev A, Gross ML, Schaefer F, Schmitt CP (2008) Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia. Nephrol Dial Transplant 23:2761\u20132767","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR30","unstructured":"EMEA (2001) European assessment report mimpara. European Medicines Agency"},{"key":"1462_CR31","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534\u20132540","journal-title":"J Clin Invest"},{"key":"1462_CR32","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"JL Reynolds","year":"2004","unstructured":"Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857\u20132867","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","volume":"103","author":"AP Guerin","year":"2001","unstructured":"Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987\u2013992","journal-title":"Circulation"},{"key":"1462_CR34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388\u2013396","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1681\/ASN.2008121277","volume":"20","author":"JB Cannata-Andia","year":"2009","unstructured":"Cannata-Andia JB, Naves-Diaz M (2009) Phosphorus and survival: key questions that need answers. J Am Soc Nephrol 20:234\u2013236","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"1462_CR37","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","volume":"73","author":"E Slatopolsky","year":"1999","unstructured":"Slatopolsky E, Brown A, Dusso A (1999) Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 73:S14\u2013S19","journal-title":"Kidney Int Suppl"},{"key":"1462_CR38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9629(15)40549-X","volume":"317","author":"E Slatopolsky","year":"1999","unstructured":"Slatopolsky E, Dusso A, Brown AJ (1999) The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure. Am J Med Sci 317:370\u2013376","journal-title":"Am J Med Sci"},{"key":"1462_CR39","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1462_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/17.suppl_2.9","volume":"17","author":"JB Cannata-Andia","year":"2002","unstructured":"Cannata-Andia JB, Fernandez-Martin JL (2002) The clinical impact of aluminium overload in renal failure. Nephrol Dial Transplant 17(Suppl 2):9\u201312","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"1462_CR41","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/S1769-7255(07)80631-6","volume":"3","author":"G London","year":"2007","unstructured":"London G, Marchais S, Guerin A, Metivier F (2007) Arterial hypertension, chronic renal insufficiency and dialysis. Nephrol Ther 3(Suppl 3):S156\u2013S161","journal-title":"Nephrol Ther"},{"key":"1462_CR42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ki.2009.60","volume":"75","author":"AJ Hutchison","year":"2009","unstructured":"Hutchison AJ (2009) Oral phosphate binders. Kidney Int 75:906\u2013914","journal-title":"Kidney Int"},{"key":"1462_CR43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252","journal-title":"Kidney Int"},{"key":"1462_CR44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","volume":"149","author":"E Ferramosca","year":"2005","unstructured":"Ferramosca E, Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P (2005) Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J 149:820\u2013825","journal-title":"Am Heart J"},{"key":"1462_CR45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","volume":"52","author":"JP Garg","year":"2005","unstructured":"Garg JP, Chasan-Taber S, Blair A, Plone M, Bommer J, Raggi P, Chertow GM (2005) Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial. Arthritis Rheum 52:290\u2013295","journal-title":"Arthritis Rheum"},{"key":"1462_CR46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxlet.2007.04.005","volume":"171","author":"SJ Damment","year":"2007","unstructured":"Damment SJ, Pennick M (2007) Systemic lanthanum is excreted in the bile of rats. Toxicol Lett 171:69\u201377","journal-title":"Toxicol Lett"},{"key":"1462_CR47","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000084653","volume":"100","author":"AJ Hutchison","year":"2005","unstructured":"Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskuhler A (2005) Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate. Nephron Clin Pract 100:c8\u2013c19","journal-title":"Nephron Clin Pract"},{"key":"1462_CR48","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1093\/ndt\/gfn310","volume":"23","author":"AJ Hutchison","year":"2008","unstructured":"Hutchison AJ, Laville M (2008) Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden. Nephrol Dial Transplant 23:3677\u20133684","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1525-139X.2007.00299.x","volume":"20","author":"TB Drueke","year":"2007","unstructured":"Drueke TB (2007) Lanthanum carbonate as a first-line phosphate binder: the \u201ccons\u201d. Semin Dial 20:329\u2013332","journal-title":"Semin Dial"},{"key":"1462_CR50","doi-asserted-by":"crossref","first-page":"c15","DOI":"10.1159\/000149239","volume":"110","author":"AJ Hutchison","year":"2008","unstructured":"Hutchison AJ, Barnett ME, Krause R, Kwan JT, Siami GA (2008) Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron Clin Pract 110:c15\u2013c23","journal-title":"Nephron Clin Pract"},{"key":"1462_CR51","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","volume":"21","author":"GB Spasovski","year":"2006","unstructured":"Spasovski GB, Sikole A, Gelev S, Masin-Spasovska J, Freemont T, Webster I, Gill M, Jones C, De Broe ME, D\u2019Haese PC (2006) Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2\u00a0years of follow-up. Nephrol Dial Transplant 21:2217\u20132224","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1525-139X.2007.00306.x","volume":"20","author":"CW McIntyre","year":"2007","unstructured":"McIntyre CW (2007) New developments in the management of hyperphosphatemia in chronic kidney disease. Semin Dial 20:337\u2013341","journal-title":"Semin Dial"},{"key":"1462_CR53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.1987.222","volume":"32","author":"HE Meema","year":"1987","unstructured":"Meema HE, Oreopoulos DG, Rapoport A (1987) Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388\u2013394","journal-title":"Kidney Int"},{"key":"1462_CR54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00365599709070348","volume":"31","author":"JF Navarro","year":"1997","unstructured":"Navarro JF, Macia ML, Gallego E, Mendez ML, Chahin J, Garcia-Nieto V, Garcia JJ (1997) Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 31:275\u2013280","journal-title":"Scand J Urol Nephrol"},{"key":"1462_CR55","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","volume":"16","author":"IB Salusky","year":"2005","unstructured":"Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Juppner H (2005) Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin\u00a0D sterols. J Am Soc Nephrol 16:2501\u20132508","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR56","doi-asserted-by":"crossref","first-page":"F1502","DOI":"10.1152\/ajprenal.00130.2009","volume":"297","author":"JM Valdivielso","year":"2009","unstructured":"Valdivielso JM, Cannata And\u00eda JB, Fern\u00e1ndez E (2009) A new role for the vitamin\u00a0D receptor activation (VDRA) in chronic kidney disease. Am J Physiol Renal Physiol 297:F1502\u2013F1509","journal-title":"Am J Physiol Renal Physiol"},{"key":"1462_CR57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","volume":"349","author":"M Teng","year":"2003","unstructured":"Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446\u2013456","journal-title":"N Engl J Med"},{"key":"1462_CR58","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R (2007) Vitamin\u00a0D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004\u20131013","journal-title":"Kidney Int"},{"key":"1462_CR59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","volume":"19","author":"T Shoji","year":"2004","unstructured":"Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin\u00a0D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179\u2013184","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR60","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","volume":"70","author":"F Tentori","year":"2006","unstructured":"Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin\u00a0D analogs. Kidney Int 70:1858\u20131865","journal-title":"Kidney Int"},{"key":"1462_CR61","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","volume":"74","author":"M Naves-Diaz","year":"2008","unstructured":"Naves-Diaz M, Alvarez-Hernandez D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D, Cannata-Andia JB (2008) Oral active vitamin\u00a0D is associated with improved survival in hemodialysis patients. Kidney Int 74:1070\u20131078","journal-title":"Kidney Int"},{"key":"1462_CR62","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","volume":"288","author":"W Xiang","year":"2005","unstructured":"Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC (2005) Cardiac hypertrophy in vitamin\u00a0D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288:E125\u2013E132","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1462_CR63","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/en.2007-0805","volume":"149","author":"DX Tishkoff","year":"2008","unstructured":"Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU (2008) Functional vitamin\u00a0D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 149:558\u2013564","journal-title":"Endocrinology"},{"key":"1462_CR64","first-page":"H1751","volume":"272","author":"TD O\u2019Connell","year":"1997","unstructured":"O\u2019Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU (1997) 1, 25- Dihydroxyvitamin\u00a0D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 272:H1751\u2013H1758","journal-title":"Am J Physiol"},{"key":"1462_CR65","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/S0021-9258(18)61537-6","volume":"262","author":"MR Walters","year":"1987","unstructured":"Walters MR, Ilenchuk TT, Claycomb WC (1987) 1, 25-Dihydroxyvitamin\u00a0D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem 262:2536\u20132541","journal-title":"J Biol Chem"},{"key":"1462_CR66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2006.12.081","volume":"103","author":"A Rahman","year":"2007","unstructured":"Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU (2007) Heart extracellular matrix gene expression profile in the vitamin\u00a0D receptor knockout mice. J Steroid Biochem Mol Biol 103:416\u2013419","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1462_CR67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","volume":"117","author":"TJ Wang","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D\u2019Agostino RB, Wolf M, Vasan RS (2008) Vitamin\u00a0D deficiency and risk of cardiovascular disease. Circulation 117:503\u2013511","journal-title":"Circulation"},{"key":"1462_CR68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","volume":"75","author":"P Ravani","year":"2009","unstructured":"Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C (2009) Vitamin\u00a0D levels and patient outcome in chronic kidney disease. Kidney Int 75:88\u201395","journal-title":"Kidney Int"},{"key":"1462_CR69","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","volume":"104","author":"N Bodyak","year":"2007","unstructured":"Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM (2007) Activated vitamin\u00a0D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A 104:16810\u201316815","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1462_CR70","doi-asserted-by":"crossref","first-page":"p76","DOI":"10.1159\/000104875","volume":"106","author":"RM Fryer","year":"2007","unstructured":"Fryer RM, Rakestraw PA, Nakane M, Dixon D, Banfor PN, Koch KA, Wu-Wong JR, Reinhart GA (2007) Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57\/BL6 mice. Nephron Physiol 106:p76\u2013p81","journal-title":"Nephron Physiol"},{"key":"1462_CR71","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","volume":"22","author":"A Cardus","year":"2007","unstructured":"Cardus A, Panizo S, Parisi E, Fernandez E, Valdivielso JM (2007) Differential effects of vitamin\u00a0D analogs on vascular calcification. J Bone Miner Res 22:860\u2013866","journal-title":"J Bone Miner Res"},{"key":"1462_CR72","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2007090993","volume":"19","author":"R Shroff","year":"2008","unstructured":"Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin\u00a0D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239\u20131246","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/qjmed\/95.12.787","volume":"95","author":"PM Timms","year":"2002","unstructured":"Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna E, Price CP, Boucher BJ (2002) Circulating MMP9, vitamin\u00a0D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95:787\u2013796","journal-title":"QJM"},{"key":"1462_CR74","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejcn.1602825","volume":"62","author":"B Hintzpeter","year":"2008","unstructured":"Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C (2008) Vitamin\u00a0D status and health correlates among German adults. Eur J Clin Nutr 62:1079\u20131089","journal-title":"Eur J Clin Nutr"},{"key":"1462_CR75","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","volume":"17","author":"X Tan","year":"2006","unstructured":"Tan X, Li Y, Liu Y (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17:3382\u20133393","journal-title":"J Am Soc Nephrol"},{"key":"1462_CR76","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D (2005) Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 68:2823\u20132828","journal-title":"Kidney Int"},{"key":"1462_CR77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","volume":"52","author":"P Alborzi","year":"2008","unstructured":"Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, Light RP, Agarwal R (2008) Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52:249\u2013255","journal-title":"Hypertension"},{"key":"1462_CR78","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","volume":"105","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC (2008) Combination therapy with AT1 blocker and vitamin\u00a0D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A 105:15896\u201315901","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1462_CR79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000151275","volume":"29","author":"N Kumar","year":"2009","unstructured":"Kumar N, Lindberg J, David K, Morris J, Menoyo J (2009) Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations. Am J Nephrol 29:71\u201378","journal-title":"Am J Nephrol"},{"key":"1462_CR80","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00467-006-0204-5","volume":"21","author":"W Seeherunvong","year":"2006","unstructured":"Seeherunvong W, Nwobi O, Abitbol CL, Chandar J, Strauss J, Zilleruelo G (2006) Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol 21:1434\u20131439","journal-title":"Pediatr Nephrol"},{"key":"1462_CR81","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1053\/j.ajkd.2007.03.008","volume":"49","author":"LA Greenbaum","year":"2007","unstructured":"Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB (2007) Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis 49:814\u2013823","journal-title":"Am J Kidney Dis"},{"key":"1462_CR82","doi-asserted-by":"crossref","unstructured":"Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez- Coto MT, Cannata-Andia JB (2003) Vitamin\u00a0D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin\u00a0D cut-off levels. Kidney Int Suppl 63:S44\u2013S48","DOI":"10.1046\/j.1523-1755.63.s85.11.x"},{"key":"1462_CR83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/ki.2008.363","volume":"74","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino M, Brancaccio D (2008) VDRAs versus calcimimetics: better safe than sorry? Kidney Int 74:966, author reply 966\u2013967","journal-title":"Kidney Int"},{"key":"1462_CR84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","volume":"24","author":"EA Gonzalez","year":"2004","unstructured":"Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin\u00a0D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24:503\u2013510","journal-title":"Am J Nephrol"},{"key":"1462_CR85","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/ndt\/17.11.1875","volume":"17","author":"JB Cannata-Andia","year":"2002","unstructured":"Cannata-Andia JB, Gomez Alonso C (2002) Vitamin\u00a0D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 17:1875\u20131878","journal-title":"Nephrol Dial Transplant"},{"key":"1462_CR86","doi-asserted-by":"crossref","first-page":"529S","DOI":"10.1093\/ajcn\/88.2.529S","volume":"88","author":"FR Greer","year":"2008","unstructured":"Greer FR (2008) 25-Hydroxyvitamin\u00a0D: functional outcomes in infants and young children. Am J Clin Nutr 88:529S\u2013533S","journal-title":"Am J Clin Nutr"},{"key":"1462_CR87","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00467-008-0842-x","volume":"23","author":"S Menon","year":"2008","unstructured":"Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin\u00a0D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23:1831\u20131836","journal-title":"Pediatr Nephrol"},{"key":"1462_CR88","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jpeds.2008.12.006","volume":"154","author":"W Seeherunvong","year":"2009","unstructured":"Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M (2009) Vitamin\u00a0D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 154:906\u2013911","journal-title":"J Pediatr"},{"issue":"Suppl 113","key":"1462_CR89","first-page":"S1","volume":"76","author":"SM Moe","year":"2009","unstructured":"Moe SM, Drueke TB, Block G, Cannata And\u00eda JB, Elder GJ, Fukagawa M, Jorgetti V, Ketteler M, Lagman CB, Levin A, Macleod M, McCann L, McCulough PA, Ott SM, Wang AY, Weisinger JR, Wheeler DC (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease related mineral and bone disorders (CKD-MBD). Kidney Int 76(Suppl 113):S1\u2013S130","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1462-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-010-1462-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1462-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T17:06:17Z","timestamp":1634922377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-010-1462-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,12]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1007\/s00467-010-1462-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,12]]}}}